MX9703461A - Nuevas composiciones basadas en una mezcla sinergistica de al menos un ligando vdr y un retinoide. - Google Patents

Nuevas composiciones basadas en una mezcla sinergistica de al menos un ligando vdr y un retinoide.

Info

Publication number
MX9703461A
MX9703461A MX9703461A MX9703461A MX9703461A MX 9703461 A MX9703461 A MX 9703461A MX 9703461 A MX9703461 A MX 9703461A MX 9703461 A MX9703461 A MX 9703461A MX 9703461 A MX9703461 A MX 9703461A
Authority
MX
Mexico
Prior art keywords
ligands
retinoids
vrd
compositions based
novel compositions
Prior art date
Application number
MX9703461A
Other languages
English (en)
Other versions
MXPA97003461A (es
Inventor
Serge Michel
Veronique Dionisius-Pouget
Original Assignee
Ct Internat De Rech S
Dermatologiques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9482603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9703461(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ct Internat De Rech S, Dermatologiques Galderma filed Critical Ct Internat De Rech S
Publication of MX9703461A publication Critical patent/MX9703461A/es
Publication of MXPA97003461A publication Critical patent/MXPA97003461A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La invencion describe una nueva combinacion de uno o más ligandos con actividad selectiva del receptor VDR y uno o más retinoides selectivos para receptores RAR-gamma con respecto a los receptores RAR-alfa, así como al uso de ésta en aplicacion cosmética y cuidados de la piel para el tratamiento de trastornos relacionados con la hiperproliferacion de células, en particular células de la piel, tal como la psoriasis.
MXPA/A/1997/003461A 1995-09-15 1997-05-12 Nuevas composiciones basadas en una mezcla sinergistica de al menos un ligando vdr y un retinoide MXPA97003461A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR95/10854 1995-09-15
FR9510854A FR2738745B1 (fr) 1995-09-15 1995-09-15 Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations
PCT/FR1996/001386 WO1997009987A1 (fr) 1995-09-15 1996-09-10 Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide

Publications (2)

Publication Number Publication Date
MX9703461A true MX9703461A (es) 1997-07-31
MXPA97003461A MXPA97003461A (es) 1997-12-01

Family

ID=

Also Published As

Publication number Publication date
BR9606648B1 (pt) 2009-01-13
WO1997009987A1 (fr) 1997-03-20
EP0788361A1 (fr) 1997-08-13
FR2738745A1 (fr) 1997-03-21
ES2181908T3 (es) 2003-03-01
NZ318430A (en) 2000-09-29
JP2898100B2 (ja) 1999-05-31
US6759396B1 (en) 2004-07-06
DE69621580T2 (de) 2003-03-13
CA2204437A1 (fr) 1997-03-20
AU6991296A (en) 1997-04-01
EP0788361B1 (fr) 2002-06-05
CA2204437C (fr) 2003-06-10
JPH10503533A (ja) 1998-03-31
DE69621580D1 (de) 2002-07-11
BR9606648A (pt) 1997-09-16
DK0788361T3 (da) 2002-07-15
ATE218349T1 (de) 2002-06-15
FR2738745B1 (fr) 1997-10-24
PT788361E (pt) 2002-11-29
AU687687B2 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
AU687687B2 (en) Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids
ZA899780B (en) Cosmetic or pharmaceutical composition containing microspheres of polymers or of fatty substances filled with at least one active product
GB9207280D0 (en) Skin care method and composition
GR3018853T3 (en) LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES.
TW280773B (es)
TR199801501T1 (xx) Yeni form�lasyon.
CA2135575A1 (fr) Composition cosmetique contenant en tant qu'agent reducteur un n-mercapto-alkyl alcanediamide ou l'un de ses sels cosmetiquement acceptable
DE69407419D1 (de) 2' oder 3' -deoxy- und 2' -dideoxy-beta-l-pentafuranonukleoside, verfahren zur herstellung und anwendung in der therapie, insbesondere als antivirale wirkstoffe
HK1003297A1 (en) Retinoid composition
DE69831404D1 (de) Verwendung von mindestens einem irvingia gabonensis-extrakt in kosmetischen und/oder pharmazeutischen produkten
CA2179778A1 (en) Deuterised active agents in transdermal application
WO1998038968A3 (de) Kosmetisches körperpflegepräparat das honig enthält und verfahren zu seiner herstellung
MY131368A (en) Synthetic detergent total body care product
ES2121463T3 (es) Uso de procisteina como agente blanqueante de la piel.
DE59803222D1 (de) Kosmetische mittel
KR960700729A (ko) 26,26,26,27,27,27-헥사플루오로-1 알파, 25-디히드록시콜레칼시페롤의 칼슘 대사 장애의 치료 용도(Use of 26,26,26,27,27,27-Hexafluoro-1alpha, 25-Dihydroxycholecalciferol for the treatment of Calcium Metabolism Disorders)
IT1282904B1 (it) Macchinario per l'esercizio dei muscoli facciali e per il miglioramento dell'aspetto estetico del viso
BG100712U (en) Biologically active composition
RU94008830A (ru) Основа для косметических средств

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees